Abstract | INTRODUCTION: METHODS: Combined data were analyzed on 39 patients with delayed gastric emptying (DGE) from 2 studies (n = 84) assessing the prokinetic effect of nizatidine CR. A single-blind placebo baseline was followed by double-blind nizatidine CR (150 and 300 mg) in randomized sequence, 2 to 5 days apart. Each dose was followed 1 hour later by an egg-beater meal, labeled with Tc99m. Gamma camera images were obtained at meal completion, 1-, 2-, 3- and 4-hour postmeal. All the 84 patients were classified at baseline with DGE (gastric retention >6.3% at 4 hours) or normal gastric emptying. RESULTS: In the 39 patients identified with DGE, change from placebo baseline (CFB) for percent gastric retention at 4-hour postmeal with nizatidine CR (150 and 300 mg) was each improved and statistically significant (P < 0.05). In a subgroup of diabetic patients with DGE (n = 10), the CFB with nizatidine CR (300 mg) was significant (P < 0.05) at 3- and 4-hour postmeal. CONCLUSIONS:
Nizatidine CR (150 and 300 mg) significantly enhanced gastric emptying of a standard meal in patients with GERD with DGE.
|
Authors | Richard W McCallum, Edwin J Zarling, Allen C Goetsch, Carl Griffin, Irene Sarosiek, Reza A Hejazi, Ralph T Doyle, Keith Rotenberg |
Journal | The American journal of the medical sciences
(Am J Med Sci)
Vol. 340
Issue 4
Pg. 259-63
(Oct 2010)
ISSN: 1538-2990 [Electronic] United States |
PMID | 20881754
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Delayed-Action Preparations
- Histamine H2 Antagonists
- Technetium
- Nizatidine
|
Topics |
- Cross-Over Studies
- Delayed-Action Preparations
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Gastric Emptying
(drug effects)
- Gastroesophageal Reflux
(diagnostic imaging, drug therapy)
- Histamine H2 Antagonists
(administration & dosage)
- Humans
- Male
- Nizatidine
(administration & dosage)
- Radionuclide Imaging
- Technetium
|